Literature DB >> 23333133

First year of life medication use and hospital admission rates: premature compared with term infants.

Leanne M A Houweling1, Irene D Bezemer, Fernie J A Penning-van Beest, Willemijn M Meijer, Richard A van Lingen, Ron M C Herings.   

Abstract

OBJECTIVE: To compare hospitalization and medication use during the first year of life in preterm-born and term-born infants. STUDY
DESIGN: Data for this retrospective cohort study were obtained from the linked PHARMO-Netherlands Perinatal Registry cohort. From this linked birth cohort, preterm infants (<37 weeks) born between 2004 and 2007 were randomly matched to 4 full-term infants. During follow-up, hospitalization and medication use were assessed. Cox proportional hazard regression models were used to estimate and compare the relative risk (RR) of hospitalization and medication use in preterm and full-term infants. Population-attributable risk percentages were calculated to estimate the proportion of hospitalizations and medication use attributable to preterm birth.
RESULTS: Among the 71,607 singletons born between 2004-2007, 4277 (6%) were born preterm. Of these, 90% were hospitalized at birth, compared with 55% of full-term infants. Preterm infants were twice as likely to be rehospitalized (RR, 2.0; 95% CI, 1.9-2.2), specifically for respiratory-related diseases. Prematurity accounted for 6% of the respiratory disease readmissions. The most frequently used outpatient drugs in the second half year of life were antibacterials for systemic use and drugs for obstructive airway diseases. Preterm infants were 50% more likely to receive a respiratory medication (RR, 1.5; 95% CI, 1.4-1.7).
CONCLUSION: In the first year of life, preterm born infants are up to 2 times more likely than full-term infants to be hospitalized or use medication, especially related to respiratory disease.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333133     DOI: 10.1016/j.jpeds.2012.12.014

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.

Authors:  Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Catherijne A J Knibbe; Anthonius de Boer; Aukje K Mantel-Teeuwisse
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

2.  Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.

Authors:  Ingeborg M Zomerdijk; Rikje Ruiter; Leanne M A Houweling; Ron M C Herings; Miriam C J M Sturkenboom; Sabine M J M Straus; Bruno H Stricker
Journal:  BMJ Open       Date:  2014-11-12       Impact factor: 2.692

3.  Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network.

Authors:  Josephina G Kuiper; Marina Bakker; Fernie J A Penning-van Beest; Ron M C Herings
Journal:  Clin Epidemiol       Date:  2020-04-29       Impact factor: 4.790

4.  Risk of infection in the first year of life in preterm children: An Austrian observational study.

Authors:  Laura Steiner; Susanne C Diesner; Peter Voitl
Journal:  PLoS One       Date:  2019-12-09       Impact factor: 3.240

5.  Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country.

Authors:  Catherine Adler; Edwige Haelterman; Patricia Barlow; Arnaud Marchant; Jack Levy; Tessa Goetghebuer
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

6.  Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study.

Authors:  Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Aukje K Mantel-Teeuwisse; Catherijne A J Knibbe; Anthonius de Boer
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

7.  Dutch trends in the use of potentially harmful medication during pregnancy.

Authors:  Eline Houben; Bernke Te Winkel; Eric A P Steegers; Ron M C Herings
Journal:  Br J Clin Pharmacol       Date:  2020-05-26       Impact factor: 4.335

8.  Cohort profile: the PHARMO Perinatal Research Network (PPRN) in the Netherlands: a population-based mother-child linked cohort.

Authors:  E Houben; L Broeders; E A P Steegers; R M C Herings
Journal:  BMJ Open       Date:  2020-09-25       Impact factor: 2.692

9.  Rates of rehospitalisation in the first 2 years among preterm infants discharged from the NICU of a tertiary children hospital in Vietnam: a follow-up study.

Authors:  Chuong Huu Thieu Do; Malene Landbo Børresen; Freddy Karup Pedersen; Ronald Bertus Geskus; Alexandra Yasmin Kruse
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.